Table III.
Characteristic | Responders who received a transplant directly after RDHAP (n=15) | Responders who did not receive a transplant (n=31) |
---|---|---|
Age, years | ||
Mean±S.D. | 60.5±9.8 | 65.4±9.0 |
Median (Min, Max) | 61 (45, 75) | 64 (48, 83) |
Bulky Disease | 5 (33%) | 9 (29%) |
Number of prior chemotherapies | ||
Mean | 2.1 | 2.4 |
Median (Min, Max) | 2 (1, 5) | 2 (1, 7) |
IPI Score | ||
0 | 1 (7%) | 2 (6%) |
1 | 4 (27%) | 10 (32%) |
2 | 6 (40%) | 7 (23%) |
3 | 4 (27%) | 10 (32%) |
4 | 0 (0%) | 2 (6%) |
Disease type | ||
Small lymphocytic | 0 (0%) | 3 (10%) |
Mantle Cell | 2 (13%) | 2 (6%) |
Follicular | 1 (7%) | 9 (29%) |
Diffuse large cell | 9 (60%) | 14 (45%) |
Nodal Marginal Zone | 0 (0%) | 1 (3%) |
High Grade, Burkitt-like | 0 (0%) | 1 (3%) |
Unclassifiable | 3 (20%) | 1 (3%) |